Article Information
History
- September 10, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Gerald Wirnsberger1,*,
- Vanessa Monteil2,
- Brett Eaton3,
- Elena Postnikova3,
- Michael Murphy3,
- Benedict Braunsfeld4,
- Ian Crozier3,
- Franz Kricek5,
- Janine Niederhöfer1,
- Alice Schwarzböck1,
- Helene Breid1,
- Anna Sanchez Jimenez1,
- Agnes Bugajska-Schretter1,
- Alexander Dohnal1,
- Christine Ruf5,
- Romana Gugenberger1,
- Astrid Hagelkruys6,
- Nuria Montserrat7,8,
- Michael R. Holbrook3,
- Chris Oostenbrink4,
- Robert H. Shoemaker9,
- Ali Mirazimi2 and
- Josef M. Penninger6,10,*
- 1Apeiron Biologics, Vienna, Austria
- 2Karolinska Institutet and Karolinska University Hospital, Unit of Clinical Microbiology, SE-17182, Stockholm, Sweden
- 3NIAID Integrated Research Facility at Fort Detrick (IRF-Frederick), Frederick, MD 21702, USA
- 4Institute for Molecular Modeling and Simulation, University of Natural Resources and Life Sciences (BOKU), Austria
- 5NBS-C BioScience & Consulting GmbH, Vienna, Austria
- 6Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria
- 7Pluripotency for Organ Regeneration, Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain
- 8Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain
- 9Chemopreventive Agent Development Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
- 10Department of Medical Genetics, Life Sciences Institute, University of British Columbia, Vancouver, Canada
- ↵*Correspondence to Gerald Wirnsberger (gerald.wirnsberger{at}apeiron-biologics.com) or Josef M. Penninger (josef.penninger{at}ubc.ca).